Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Buys $148,540.00 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDNGet Free Report) Director Steven D. Cosler bought 7,000 shares of the business’s stock in a transaction dated Tuesday, November 19th. The shares were bought at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the purchase, the director now directly owns 17,713 shares in the company, valued at approximately $375,869.86. This represents a 65.34 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

Guardian Pharmacy Services Stock Up 4.6 %

Shares of NYSE GRDN opened at $23.08 on Friday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $23.35.

Guardian Pharmacy Services (NYSE:GRDNGet Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The business had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. Equities research analysts expect that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Raymond James assumed coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price objective for the company. Truist Financial lifted their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Finally, Stephens initiated coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price objective for the company.

Check Out Our Latest Report on GRDN

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Stephens Inc. AR bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at approximately $189,000. Virtu Financial LLC bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at approximately $279,000. Barclays PLC bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $311,000. Point72 DIFC Ltd bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $573,000. Finally, Royce & Associates LP bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $1,260,000.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

See Also

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.